Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured hepatitis C infection

We conducted an external validation of six HCC prediction models for UK patients with cirrhosis HCV virological cure.

Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study

We examined the impact of the introduction of direct-acting antiviral (DAA) therapies on hepatitis C related decompensated cirrhosis (DC) through analysis of population-based data from Scotland.